These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 21816829)
1. Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1. Park YP; Choi SC; Kiesler P; Gil-Krzewska A; Borrego F; Weck J; Krzewski K; Coligan JE Blood; 2011 Sep; 118(11):3019-27. PubMed ID: 21816829 [TBL] [Abstract][Full Text] [Related]
2. 4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cells. Kim YJ; Han MK; Broxmeyer HE Blood; 2008 Feb; 111(3):1378-86. PubMed ID: 18024793 [TBL] [Abstract][Full Text] [Related]
3. A functional polymorphism in the NKG2D gene modulates NK-cell cytotoxicity and is associated with susceptibility to Human Papilloma Virus-related cancers. Espinoza JL; Nguyen VH; Ichimura H; Pham TT; Nguyen CH; Pham TV; Elbadry MI; Yoshioka K; Tanaka J; Trung LQ; Takami A; Nakao S Sci Rep; 2016 Dec; 6():39231. PubMed ID: 27995954 [TBL] [Abstract][Full Text] [Related]
4. Regulation of ligands for the NKG2D activating receptor. Raulet DH; Gasser S; Gowen BG; Deng W; Jung H Annu Rev Immunol; 2013; 31():413-41. PubMed ID: 23298206 [TBL] [Abstract][Full Text] [Related]
5. Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells. Benitez AC; Dai Z; Mann HH; Reeves RS; Margineantu DH; Gooley TA; Groh V; Spies T Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4081-6. PubMed ID: 21321202 [TBL] [Abstract][Full Text] [Related]
6. Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway. Ampudia-Mesias E; Puerta-Martinez F; Bridges M; Zellmer D; Janeiro A; Strokes M; Sham YY; Taher A; Castro MG; Moertel CL; Pluhar GE; Olin MR Neurotherapeutics; 2021 Jul; 18(3):2131. PubMed ID: 33929711 [No Abstract] [Full Text] [Related]
7. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells. Molfetta R; Quatrini L; Capuano C; Gasparrini F; Zitti B; Zingoni A; Galandrini R; Santoni A; Paolini R Eur J Immunol; 2014 Sep; 44(9):2761-70. PubMed ID: 24846123 [TBL] [Abstract][Full Text] [Related]
9. NKG2D Receptor and Its Ligands in Host Defense. Lanier LL Cancer Immunol Res; 2015 Jun; 3(6):575-82. PubMed ID: 26041808 [TBL] [Abstract][Full Text] [Related]
10. Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation. Zhu S; Phatarpekar PV; Denman CJ; Senyukov VV; Somanchi SS; Nguyen-Jackson HT; Mace EM; Freeman AF; Watowich SS; Orange JS; Holland SM; Lee DA Blood; 2014 Jul; 124(3):403-11. PubMed ID: 24891320 [TBL] [Abstract][Full Text] [Related]
11. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway. Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601 [TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells. Quatrini L; Molfetta R; Zitti B; Peruzzi G; Fionda C; Capuano C; Galandrini R; Cippitelli M; Santoni A; Paolini R Sci Signal; 2015 Oct; 8(400):ra108. PubMed ID: 26508790 [TBL] [Abstract][Full Text] [Related]
13. A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells. Chang YH; Connolly J; Shimasaki N; Mimura K; Kono K; Campana D Cancer Res; 2013 Mar; 73(6):1777-86. PubMed ID: 23302231 [TBL] [Abstract][Full Text] [Related]
14. Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives. Rados M; Landegger A; Schmutzler L; Rabidou K; Taschner-Mandl S; Fetahu IS Cancer Metastasis Rev; 2024 Sep; ():. PubMed ID: 39294470 [TBL] [Abstract][Full Text] [Related]
15. Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease. Fernández-Soto D; García-Jiménez ÁF; Casasnovas JM; Valés-Gómez M; Reyburn HT Front Immunol; 2024; 15():1273942. PubMed ID: 38410511 [TBL] [Abstract][Full Text] [Related]
16. Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in Anthofer M; Windisch M; Haller R; Ehmann S; Wrighton S; Miller M; Schernthanner L; Kufferath I; Schauer S; Jelušić B; Kienesberger S; Zechner EL; Posselt G; Vales-Gomez M; Reyburn HT; Gorkiewicz G Front Immunol; 2024; 15():1282680. PubMed ID: 38318189 [TBL] [Abstract][Full Text] [Related]
17. The Role of NKG2D and Its Ligands in Autoimmune Diseases: New Targets for Immunotherapy. Wei L; Xiang Z; Zou Y Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139373 [TBL] [Abstract][Full Text] [Related]
18. Coordinated Priming of NKG2D Pathway by IL-15 Enhanced Functional Properties of Cytotoxic CD4 Wang T; Wei L; Meng S; Song W; Chen Y; Li H; Zhao Q; Jiang Z; Liu D; Ren H; Hong X Inflammation; 2023 Oct; 46(5):1587-1601. PubMed ID: 37415045 [TBL] [Abstract][Full Text] [Related]
19. Preventing Surgery-Induced NK Cell Dysfunction Using Anti-TGF-β Immunotherapeutics. Market M; Tennakoon G; Scaffidi M; Cook DP; Angka L; Ng J; Tanese de Souza C; Kennedy MA; Vanderhyden BC; Auer RC Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498937 [TBL] [Abstract][Full Text] [Related]